MEHALICK DAVID (CEO and President) sold 40.0% of their position (1.20M shares) of COEPTIS THERAPEUTICS INC. on the open market
Insider sale on the open market — a major position exit. Check remaining position size for full context.
S · 1 sale
Filed: 11/18/2021ACC: 0001683168-21-005808
DirectorOfficer10% Owner· CEO and President
Since Feb 2021
-1.20M
Net shares
Net seller
$0.00
Total acquired
1
Open market trades
0B · 1S
1
Total transactions
1.20M disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−1.20M
Price / share
—
Trade value
—
% of position
40.0%
11/16/2021
3M→1.80M
Total
Net shares
−1.20M
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 11/16/2021 | S · Sale | −1.20M | — | — | 40.0% | 3M | 1.80M |
| Total | −1.20M | $0.00 | ||||||
Derivative Transactions0
No derivative transactions reported